Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBIDECARENONE vs UBROGEPANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UBIDECARENONE vs UBROGEPANT: Safety Overview

Metric UBIDECARENONE UBROGEPANT
Total FAERS Reports 361 2,531
Deaths Reported 5 49
Death Rate 1.4% 1.9%
Hospitalizations 194 145
Average Patient Age 60.7 yrs 49.2 yrs
% Female Patients 82.6% 83.6%
FDA Approval Date N/A Dec 23, 2019
Manufacturer Energique, Inc. Allergan, Inc.
Route ORAL ORAL
Marketing Status N/A Prescription